Crossref
Targeting pericytes to overcome resistance to tumor anti-angiogenic therapy
Science Bulletin · 2026-10
DOI: 10.1016/j.scib.2026.10.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Bulletin, 2026-10. Verfasst von Chao Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310058, China. Electronic address: shenchao@him.cas.cn. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310058, China. Electronic address: shenchao@him.cas.cn.
- Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310058, China.
- Department of Systems Biology and Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA. Electronic address: jianchen@coh.org.
Zitieren
APA
Shen, C., Peng, H., & Chen, J. (2026). Targeting pericytes to overcome resistance to tumor anti-angiogenic therapy. Science Bulletin. https://doi.org/10.1016/j.scib.2026.10.034
Vancouver
Shen C, Peng H, Chen J. Targeting pericytes to overcome resistance to tumor anti-angiogenic therapy. Science Bulletin. 2026. doi:10.1016/j.scib.2026.10.034
BibTeX
@article{Shen2026,
author = {Shen, Chao and Peng, Haifeng and Chen, Jianjun},
title = {Targeting pericytes to overcome resistance to tumor anti-angiogenic therapy},
journal = {Science Bulletin},
year = {2026},
doi = {10.1016/j.scib.2026.10.034}
}
EUVIMED